search
Back to results

eNose-TB: Electronic Nose for Tuberculosis Screening

Primary Purpose

Tuberculosis

Status
Recruiting
Phase
Not Applicable
Locations
Indonesia
Study Type
Interventional
Intervention
exhaled breath sampling
exhaled breath sampling
Sponsored by
Gadjah Mada University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Tuberculosis focused on measuring electronic-nose, breath test, tuberculosis, screening

Eligibility Criteria

4 Years - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

- Inclusion Criteria:

Validation Phase (Group 1):

  • Adult and children
  • Suspected of having TB
  • Agree to participate in the study
  • Able to produce exhaled air samples
  • Able to produce samples for Xpert MTB/Rif examination

Screening Phase (Group 2):

  • Adult and children
  • Agree to participate in the study
  • Able to produce exhaled air samples
  • Currently not in TB treatment

    - Exclusion Criteria

  • Invalid measurements of breath tests
  • Incomplete CXR data
  • Missing specimens
  • Unable to breath normally for 2 minutes due to respiratory illness

Sites / Locations

  • Balai Kesehatan Masyarakat KlatenRecruiting
  • Primary health centers

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Presumptive TB patients (395 participants - adult and children)

Residents of area with high risk of TB (1383 participants - adult and children)

Arm Description

The participants breathe normally using a mask for 2 times then they are asked to inhale and exhale in a forced expiratory volume to the air collecting bag until the collecting bag is full.

The participants breathe normally using a mask for 2 times then they are asked to inhale and exhale in a forced expiratory volume to the air collecting bag until the collecting bag is full.

Outcomes

Primary Outcome Measures

diagnostic accuracy of electronic nose signal in tuberculosis
sensitivity, specificity, positive predictive value, negative predictive value of e-nose signal in diagnosing TB

Secondary Outcome Measures

Full Information

First Posted
September 10, 2020
Last Updated
March 27, 2022
Sponsor
Gadjah Mada University
search

1. Study Identification

Unique Protocol Identification Number
NCT04567498
Brief Title
eNose-TB: Electronic Nose for Tuberculosis Screening
Official Title
eNose-TB: Electronic Nose for Tuberculosis Screening in Indonesia
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Recruiting
Study Start Date
December 2, 2021 (Actual)
Primary Completion Date
December 31, 2022 (Anticipated)
Study Completion Date
December 31, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Gadjah Mada University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
An electronic-nose (e-nose) had been investigated as a diagnostic tool for tuberculosis by examining exhaled breath of the patients. Universitas Gadjah Mada has developed an e-nose device for TB diagnostic tool. Here the investigators test the device in order to analyze the sensitivity and specificity electronic-nose as a screening tool for tuberculosis.
Detailed Description
The study population consists of 2 groups: Group 1 - presumptive TB patients. Group 2 - residents of area with high risk of TB. Study participants provide written informed consent. The participants are asked to breathe normally using a mask for 2 times then inhale and exhale in a forced expiratory volume to the air collecting bag until the collecting bag is full (two times). The collecting bag is sealed and connected to the e-nose machine via a collecting hose and HEPA-filter protecting the e-nose from microbes. The breath pattern will be recorded in the e-nose device, which is connected to a laptop that will display the recorded breath pattern. Other data are collected: clinical symptoms, results of chest X-ray, smear microscopic, and Xpert MTB/Rif examinations.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tuberculosis
Keywords
electronic-nose, breath test, tuberculosis, screening

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
The Validation phase involves suspected TB patients (Group 1) and the Screening phase involves residents of area with high risk of TB (Group 2)
Masking
ParticipantInvestigatorOutcomes Assessor
Masking Description
The study use a triple-blind masking, in which the research subjects, breath sample takers, and laboratory sample examiners do not know the results of each sampling that has been done. The final data processor is also blinded to the results of Xpert or other laboratory examinations. The breath sampling data is saved in graphic form which interpretation will be carried out later by the data processor at the final stage.
Allocation
Non-Randomized
Enrollment
1778 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Presumptive TB patients (395 participants - adult and children)
Arm Type
Experimental
Arm Description
The participants breathe normally using a mask for 2 times then they are asked to inhale and exhale in a forced expiratory volume to the air collecting bag until the collecting bag is full.
Arm Title
Residents of area with high risk of TB (1383 participants - adult and children)
Arm Type
Experimental
Arm Description
The participants breathe normally using a mask for 2 times then they are asked to inhale and exhale in a forced expiratory volume to the air collecting bag until the collecting bag is full.
Intervention Type
Other
Intervention Name(s)
exhaled breath sampling
Other Intervention Name(s)
GeNose exhaled breath sampling
Intervention Description
The participants are requested to quietly sit and breathe to the air collecting bag until the collecting bag is full. The collecting bag is sealed and connected to the e-nose machine via a collecting hose and HEPA-filter. The data are read and stored in the e-nose machine.
Intervention Type
Other
Intervention Name(s)
exhaled breath sampling
Other Intervention Name(s)
GeNose exhaled breath sampling
Intervention Description
The participants are requested to quietly sit and breathe to the air collecting bag until the collecting bag is full. The collecting bag is sealed and connected to the e-nose machine via a collecting hose and HEPA-filter. The data are read and stored in the e-nose machine.
Primary Outcome Measure Information:
Title
diagnostic accuracy of electronic nose signal in tuberculosis
Description
sensitivity, specificity, positive predictive value, negative predictive value of e-nose signal in diagnosing TB
Time Frame
2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
4 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
- Inclusion Criteria: Validation Phase (Group 1): Adult and children Suspected of having TB Agree to participate in the study Able to produce exhaled air samples Able to produce samples for Xpert MTB/Rif examination Screening Phase (Group 2): Adult and children Agree to participate in the study Able to produce exhaled air samples Currently not in TB treatment - Exclusion Criteria Invalid measurements of breath tests Incomplete CXR data Missing specimens Unable to breath normally for 2 minutes due to respiratory illness
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Antonia Saktiawati, MD, PhD
Phone
+6281227976434
Email
a.morita@ugm.ac.id
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yodi Mahendradhata, MD, MSc, PhD
Organizational Affiliation
Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Antonia Saktiawati, MD, PhD
Organizational Affiliation
Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada
Official's Role
Principal Investigator
Facility Information:
Facility Name
Balai Kesehatan Masyarakat Klaten
City
Klaten
State/Province
Central Java
ZIP/Postal Code
50131
Country
Indonesia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sigit Armunanto, dr., M.Kes
Facility Name
Primary health centers
City
Yogyakarta
Country
Indonesia
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Suharna
Phone
+628156898290

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
33882070
Citation
Saktiawati AMI, Triyana K, Wahyuningtias SD, Dwihardiani B, Julian T, Hidayat SN, Ahmad RA, Probandari A, Mahendradhata Y. eNose-TB: A trial study protocol of electronic nose for tuberculosis screening in Indonesia. PLoS One. 2021 Apr 21;16(4):e0249689. doi: 10.1371/journal.pone.0249689. eCollection 2021.
Results Reference
derived

Learn more about this trial

eNose-TB: Electronic Nose for Tuberculosis Screening

We'll reach out to this number within 24 hrs